# Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%

> **NCT01452009** · PHASE3 · WITHDRAWN · sponsor: **Alcon Research**

## Conditions studied

- Open Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Travoprost Ophthalmic Solution, 0.004% (New Formulation)
- **DRUG:** TRAVATAN®

## Key facts

- **NCT ID:** NCT01452009
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-11
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Management Decision
- **Last updated:** 2012-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01452009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01452009, "Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01452009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*